|
i think that in retrospect this sounds like a no duh trial. alpha 1 antitrypsin is responsible for protecting the lung and liver, which are 2 major gvhd sites. it protects them by reducing inflammation. i would hope this makes its way to tria
l quickly since there is a reasonable track record and history in copd patients with low alpha 1 levels
__________________
MDS RCMD w/grade 2-3 fibrosis. Allo-MUD Feb 26, 2014. Relapsed August 2014. Free and clear of MDS since November 2014 after treatment with Vidaza and Rituxan. Experiencing autoimmune attack on CNS thought to be GVHD, some gut, skin and ocular cGVHD. Neuropathy over 80% of body.
|